Eden Research PLC
LSE:EDEN
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
P
|
PerkinElmer Inc
LSE:0KHE
|
US |
|
Sos Ltd
NYSE:SOS
|
CN |
|
Pernod Ricard SA
PAR:RI
|
FR |
|
goeasy Ltd
TSX:GSY
|
CA |
|
A
|
Adra Gayrimenkul Yatirim Ortakligi AS
IST:ADGYO.E
|
TR |
|
Cizzle Biotechnology Holdings PLC
LSE:CIZ
|
UK |
|
Hensoldt AG
XETRA:HAG
|
DE |
|
M
|
Manaksia Ltd
NSE:MANAKSIA
|
IN |
Operating Margin
Operating Margin shows how much profit a company makes from its regular business activities after covering operating costs. It helps measure how efficiently the company turns sales into profit.
Operating Margin shows how much profit a company makes from its regular business activities after covering operating costs. It helps measure how efficiently the company turns sales into profit.
Peer Comparison
| Country | Company | Market Cap |
Operating Margin |
||
|---|---|---|---|---|---|
| UK |
|
Eden Research PLC
LSE:EDEN
|
17.5m GBP |
Loading...
|
|
| US |
|
Corteva Inc
NYSE:CTVA
|
57.4B USD |
Loading...
|
|
| CA |
|
Nutrien Ltd
TSX:NTR
|
50.7B CAD |
Loading...
|
|
| CN |
|
Qinghai Salt Lake Industry Co Ltd
SZSE:000792
|
194.1B CNY |
Loading...
|
|
| CL |
|
Sociedad Quimica y Minera de Chile SA
NYSE:SQM
|
23.8B USD |
Loading...
|
|
| US |
|
CF Industries Holdings Inc
NYSE:CF
|
20B USD |
Loading...
|
|
| CN |
|
Zangge Mining Co Ltd
SZSE:000408
|
129.2B CNY |
Loading...
|
|
| NO |
|
Yara International ASA
OSE:YAR
|
142.9B NOK |
Loading...
|
|
| SA |
|
SABIC Agri-Nutrients Company SJSC
SAU:2020
|
53.8B SAR |
Loading...
|
|
| RU |
|
PhosAgro PAO
MOEX:PHOR
|
929.4B RUB |
Loading...
|
|
| CN |
|
Shandong Hualu-Hengsheng Chemical Co Ltd
SSE:600426
|
75.7B CNY |
Loading...
|
Market Distribution
| Min | -195 650% |
| 30th Percentile | 0% |
| Median | 0.1% |
| 70th Percentile | 0.2% |
| Max | 4 630.7% |
Other Profitability Ratios
Eden Research PLC
Glance View
Eden Research Plc offers sustainable solutions for crop protection, animal health and consumer products in the United Kingdom and rest of Europe. The company is headquartered in Oxford, Oxfordshire and currently employs 11 full-time employees. The company went IPO on 2012-05-11. The firm develops and supplies biopesticide products and natural microencapsulation technologies to the global crop protection, animal health and consumer products industries. Its products are formulated with terpene ingredients, which are based on natural plant defense metabolites. The Company’s products include Mevalone and Cedroz. Mevalone is a foliar bio-fungicide, which is focused on diseases affecting grapes, and other fruit and vegetable crops. Cedroz is a bionematicide that targets free living nematodes, which are parasitic worms that affect a range of fruit and vegetable crops globally. The Company’s subsidiary is TerpeneTech (Ireland) Limited.
See Also
Operating Margin is calculated by dividing the Operating Income by the Revenue.
The current Operating Margin for Eden Research PLC is -69.3%, which is above its 3-year median of -71.7%.
Over the last 3 years, Eden Research PLC’s Operating Margin has increased from -184.5% to -69.3%. During this period, it reached a low of -184.5% on Jun 30, 2022 and a high of -50.8% on Jun 30, 2024.
